PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
نویسندگان
چکیده
منابع مشابه
Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders
In the last decade, the incidence of metabolic disorders has increased drastically worldwide and is becoming a global health threat. Studies have shown that the pathogenesis and co-morbidities of diseases such as diabetes, gout, and atherosclerosis involve chronic low-grade inflammation and metabolic changes (1). As this inflammation is triggered by endogenous substances, instead of pathogens, ...
متن کاملcxcr4: a potential chemokine receptor for future regenerative therapeutic target
understanding the molecular mechanisms in regeneration could help the stem cell therapists to improve the clinical practices and could be considered a major milestone in the translation of stem cell research to clinics. chemokines have been described as one of the most significant singling networks in stem cells homing and regeneration of damaged organs. cxcr4/cxcl12 has been known as a key pla...
متن کاملRationally designed PPARδ-specific agonists and their therapeutic potential for metabolic syndrome.
The peroxisome proliferator-activated receptor (PPAR) family of nuclear receptors regulates a wide variety of lipid-related genes, including those responsible for adipose differentiation, cholesterol metabolism, and lipidmetabolism and transport. There are three different PPAR nuclear receptors, with different localizations and specializations. PPARα is primarily expressed in the liver, heart, ...
متن کاملIron deficiency in pulmonary arterial hypertension: a potential therapeutic target.
Iron deficiency is known to be common and detrimental in chronic left heart failure, where parenteral iron treatment has been shown to improve exercise capacity, New York Heart Association functional class and patient wellbeing. There is now increasing interest in the role of iron in the natural history of pulmonary arterial hypertension (PAH). Iron availability influences the pulmonary vasocon...
متن کاملPPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus. PPARα and PPARγ anti-inflammatory, antiproliferative and antiangiogenic properties in cardiovascular cells were extensively clarified in a variety of i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Hypertension
سال: 2019
ISSN: 2090-0384,2090-0392
DOI: 10.1155/2019/7809216